CN116445465A - Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant - Google Patents
Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant Download PDFInfo
- Publication number
- CN116445465A CN116445465A CN202210816219.3A CN202210816219A CN116445465A CN 116445465 A CN116445465 A CN 116445465A CN 202210816219 A CN202210816219 A CN 202210816219A CN 116445465 A CN116445465 A CN 116445465A
- Authority
- CN
- China
- Prior art keywords
- streptomyces
- glucose isomerase
- strain
- corset
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108700040099 Xylose isomerases Proteins 0.000 title claims abstract description 78
- 241000187747 Streptomyces Species 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title abstract description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000004321 preservation Methods 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims abstract description 5
- 238000002703 mutagenesis Methods 0.000 claims description 18
- 231100000350 mutagenesis Toxicity 0.000 claims description 18
- 235000021433 fructose syrup Nutrition 0.000 claims description 4
- 238000003259 recombinant expression Methods 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 238000000855 fermentation Methods 0.000 abstract description 27
- 230000004151 fermentation Effects 0.000 abstract description 27
- 102000004190 Enzymes Human genes 0.000 abstract description 17
- 108090000790 Enzymes Proteins 0.000 abstract description 17
- 238000012216 screening Methods 0.000 abstract description 9
- 230000001976 improved effect Effects 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 239000006228 supernatant Substances 0.000 description 16
- 229930091371 Fructose Natural products 0.000 description 15
- 239000005715 Fructose Substances 0.000 description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 8
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 7
- 238000009395 breeding Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 101150038987 xylR gene Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 229910010271 silicon carbide Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 2
- 229950006334 apramycin Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000003828 downregulation Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000003262 industrial enzyme Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 235000019681 Low Energy Density Foods Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000001105 Phosphofructokinases Human genes 0.000 description 1
- 108010069341 Phosphofructokinases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- PYMYPHUHKUWMLA-MROZADKFSA-N aldehydo-L-ribose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-MROZADKFSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000081 effect on glucose Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- XNCMOUSLNOHBKY-UHFFFAOYSA-H iron(3+);trisulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O XNCMOUSLNOHBKY-UHFFFAOYSA-H 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01005—Xylose isomerase (5.3.1.5)
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K11/00—Fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to the technical field of genetic engineering, and discloses a method for efficiently expressing glucose isomerase in Streptomyces corset and a recombinant mutant. The Streptomyces corset engineering bacteria constructed by the method can produce glucose isomerase with high yield, is environment-friendly because of not carrying antibiotic screening marks, and can ensure the production stability of the glucose isomerase. The invention also provides a mutant strain Streptomyces rust brown JKX, the preservation number is CCTCC NO: M20221030, the fermentation enzyme activity is up to 925.3U/ml, which is improved by about 58.52% compared with that of the parent strain, the mutant strain Streptomyces rust brown is widely applicable to the production of glucose isomerase, the production cost is reduced, and the application prospect is wide.
Description
Technical Field
The invention relates to the technical fields of genetic engineering and protein engineering, in particular to a glucose isomerase mutant and application thereof.
Background
Glucose isomerase (Glucose isomerase, GI) is also known as xylose isomerase (ec 5.3.1.5), which catalyzes the isomerisation of glucose to fructose, and also the isomerisation of xylose to xylulose. Glucose isomerase is one of the most important industrial enzymes since fructose is the main sweetener for beverages and foods. In addition, pentoses and hexoses are also good substrates for glucose isomerase, including D-ribose, L-arabinose, L-rhamnose and D-allose. GI is also used to produce rare sugars that have important pharmaceutical applications, for example, GI can efficiently catalyze the conversion of L-arabinose to L-ribose, an important component of nucleosides, glycosyl complexes, and oligonucleotides antiviral and anticancer drugs.
In industry, the most important use of GI is to use its activity in catalyzing the conversion of glucose to fructose for the production of high fructose syrup (HFCS). Fructose is a natural ketohexose and is the highest known sugar, which is abundant in honey and fruit. Fructose is predicted to be a new source of functional sugars that globally replaces sucrose and glucose in the 21 st century. Fructose bypasses the rate-limiting enzyme in glycolysis (phosphofructokinase), and the rate of decomposition of fructose in the liver is faster than glucose. The metabolic intensity of fructose depends on the concentration of fructose and is not affected by insulin. Therefore, the intake of fructose by human body can not cause serious postprandial blood sugar peak and hypoglycemia symptoms which are easily caused by the intake of glucose and sucrose, and the potential factors for inducing diabetes are eliminated. Thus being a healthy sugar which can be eaten by diabetics. Fructose is used in many countries to produce low-energy foods, infant foods, and food for weak people, as well as nutritional and therapeutic foods, because of its low calorific value, water-retaining properties, freezing resistance, corrosion resistance, flavor enhancement, and affinity. The European and American countries use fructose in sweets and beverages without sucrose. As specified by canadian law, all beverages must use high fructose syrup as a sweetener. Statistics prove that the high fructose syrup in 2013 is eliminatedThe consumption is 10 7 Ton/year is the most produced product of industrial enzymes, and thus the amount of glucose isomerase used is also huge.
The current global production of glucose isomerase is mainly monopolized by two companies, dupont and novelin in denmark, usa. The most of the production strains are Streptomyces corsetStreptomyces rubiginosus) And bacillus coagulansBacillus coagulans)。
Glucose isomerase genes are ubiquitous in prokaryotes, and are found in a wide variety of microorganisms such as E.coli, streptomyces, and lactic acid bacteria. In order to increase the expression of glucose isomerase in the early stage, a method of optimizing a medium is mainly used. The former findings that the addition of D-xylose to the fermentation medium can increase the expression of glucose isomerase, but the addition of D-xylose increases the industrial production cost, and later findings that the addition of starch, glucose, sorbitol, glycerol, etc. can achieve the effect of 75% of the addition of D-xylose. Later, bejar S et al found that the strong promoter could increase the expression level of glucose isomerase, and that the strong promoter (P1) was used to replace the original promoter of glucose isomerase gene, and found that the strain increased the expression level of glucose isomerase by 7 times compared with the xylose-induced wild strain. However, the expression level of glucose isomerase is still low and cannot meet the requirements of industrial production. Therefore, the glucose isomerase high-yield strain with independent intellectual property is constructed, the production cost is reduced, the industrial production is realized, and the need is felt.
Disclosure of Invention
The invention aims to construct a Streptomyces corset strain with high glucose isomerase yield, so as to be applied to the industrial production of glucose isomerase. The applicant firstly constructs and obtains a streptomyces rusticans strain for recombining and expressing glucose isomerase genes, then carries out ultraviolet mutagenesis on the streptomyces rusticans strain, and screens and obtains mutant strains with obviously improved glucose isomerase yield, thereby being beneficial to reducing the production cost of the enzyme and promoting the wide application of glucose isomerase.
In one aspect, the invention provides an engineering strain of a strain of Streptomyces corset with high glucose isomerase yield, which carries genes for expressing glucose isomerase.
The gene sequence of the glucose isomerase is SEQ ID NO. 1, and the encoded amino acid sequence is SEQ ID NO. 2.
One aspect of the invention provides a mutant strain Streptomyces rust brown JKX%Streptomyces rubiginosusJKX 102) has been preserved in China center for type culture collection (CCTCC NO: M20221030) of university of Wuhan, china, at 7.5 of 2022.
The invention also provides a method for producing glucose isomerase, which takes the streptomyces rustoffii as a fermentation strain.
The invention also provides glucose isomerase which is obtained by fermenting the streptomyces rustoffii.
Advantageous effects
The invention firstly expresses glucose isomerase gene in a Streptomyces corset host, and constructs engineering strain Streptomyces corset JKX101 for recombinant expression of the enzyme. The glucose isomerase activity in the supernatant of the shake flask fermentation and the 15L tank fermentation of the strain reaches 62.5U/mL and 583.7U/mL respectively.
In order to increase the yield of glucose isomerase, the applicant uses Streptomyces rust brown JKX101 as an initial strain, and screens and obtains a mutant strain Streptomyces rust brown JKX102 by an ultraviolet mutagenesis method. The glucose isomerase in the shake-flask fermentation supernatant of the mutant strain is as high as 94.6U/mL, which is 51.28% higher than that of the parent strain; the glucose isomerase in 15L tank fermentation crude enzyme liquid has the enzyme activity as high as 925.3U/mL, which is improved by 58.52% compared with the starting strain, and unexpected technical effects are obtained. The mutant strain can be widely applied to the production of glucose isomerase, is beneficial to reducing the production cost of the glucose isomerase and promotes the application of the glucose isomerase.
Drawings
FIG. 1 is a pXW403 plasmid map;
FIG. 2 is a diagram of SDS-PAGE electrophoretic analysis of fermentation supernatant of Streptomyces carborundum JKX 102;
biological material preservation information
Mutant strain rust palmStreptomyces chromogenes JKX [ ]Streptomyces rubiginosusJKX 102), the preservation number is CCTCC NO: M20221030, and the preservation is carried out in China Center for Type Culture Collection (CCTCC), address: chinese, wuhan, university of Wuhan, post code: 430072 and the preservation time is 2022, 7, 5 days.
Detailed Description
The method of the present invention will be further described with reference to examples, in which the experimental method without specifying the specific conditions in the examples may be performed under conventional conditions, such as those described in Streptomyces genetic manipulation laboratory Manual written in Hopwood (D.A.), etc., or under conditions recommended by the manufacturer. The present invention may be better understood and appreciated by those skilled in the art by reference to examples. However, the method of implementing the present invention should not be limited to the specific method steps described in the embodiments of the present invention.
The formula of the culture medium related in the embodiment of the invention is as follows:
LB plate: 1% of tryptone, 0.5% of yeast powder, 1% of NaCl and 1.5% of agar powder;
MS medium: mannitol 20 g, soybean cake powder 20 g, agar powder 20 g, pH value adjusted to 7.2-7.4, and tap water was used to fix volume to 1,000, 000 ml.
SS medium: oxoid Tryptic Soy Broth (TSB) 30 g,15g tryptone, 10 g K 2 HPO 4 , pH 7.2。
SPP medium: glucose 30 g, yeast extract 2 g, sodium chloride 2 g, citric acid 2 g, ammonium sulfate 2 g, magnesium sulfate heptahydrate 2 g, dipotassium phosphate 4 g, ferric sulfate heptahydrate 0.05 g, zinc sulfate heptahydrate 0.05 g, manganese sulfate tetrahydrate 0.05 g, pH7.2.
GI Activity was determined using spectrophotometric analysis, and GI in one enzyme activity unit was defined as the amount of enzyme required to produce 1. Mu. Mol fructose per minute. The method comprises the following steps: 100. mu.l of the fermentation supernatant (containing GI) was added to the mixed solution (5 ml of 70% glucose, 4 ml of 0.2M phosphate buffer pH 7.5,0.5 ml of 0.5M magnesium sulfate, 0.5 ml of 0.01M cobalt chloride), and the mixture was left to stand at 70 o C,150 rpm, for 30 min. The reaction was then quenched by the addition of 5 ml of 0.5M perchloric acid. Taking the solution 0.1ml dilution to a suitable multiple (final fructose concentration of 10-50. Mu.g/ml), 1ml of the above solution was taken and added with 0.2ml of L-cysteine hydrochloride solution (0.12%, w/v) and 6 ml of 70% sulfuric acid at 60 o C, standing for 10min, then standing on ice for 1.5 min, and then allowing to reach room temperature. The absorbance was then measured at an absorption wavelength of 560 nm. The fructose concentration can be calculated through a standard curve.
EXAMPLE 1 construction of glucose isomerase-integrating expression plasmid pXW403
Through literature studies, xylR genes have negative regulation effect on Glucose Isomerase (GI) gene expression. The present patent thus employs insertion of a glucose isomerase gene expression cassette at the xylR position. On one hand, the negative regulation effect of the expression of the xylR gene glucose isomerase can be eliminated, and on the other hand, the glucose isomerase gene can be inserted, so that the genetic operation steps are simplified. The glucose isomerase integrated expression plasmid pXW403 is constructed by taking pSP72 as a framework, and the xylR genes of 500 bp are respectively connected to the upstream and downstream of the glucose isomerase expression cassette, and the constructed pXW403 vector map is shown in FIG. 1. Meanwhile, the streptomycete promoter PrrnA (SEQ ID NO: 3) is used as a promoter for expressing glucose isomerase, so that the expression of the glucose isomerase is promoted. The primers used were as follows:
assxylR left F:tcgactctagaggatcccagcaccgtgacgcggtgga
assxylR left Rv:ggtcgtcggcggagaggacccggcgggccgcgggagc
ass403-GI-F: ccatgattacgaattgtacgtaaagcttggatccatggcagcaccgtgacgcggtggaagttgcacc
ass403-GI-Rv:gtatctagagctagcgggcccatggcgcggtgtccaccctggtcgacgagctcatccgct
assxylR right F:gcggcgcgtatgcgcttgcgaagttggcctcgttggc
assxylR right Rv:gagctcggtacccggggatccgcggtgtccaccctgg
assrrnA-F: gccgacgaagtctagagacccgcctcctgcgcagggtggagc
assrrnA-Rv: ctcgctgaggctatttcacaccacgagagcggaacagtcggag
ass255-pSP72-F: gaatcatggcgcgggtgccctgagttgctggcgtttttccataggctccgccc
ass255-pSP72-Rv:attgaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattcc
the DNA sequence of the synthesized glucose isomerase gene, SEQ ID NO:1 (which encodes the amino acid sequence of SEQ ID NO: 2), was cloned into the pUC57 plasmid and designated pUC57-gi.
The newly activated Streptomyces corset spores were inoculated into 25 mL of SS liquid medium, shake-cultured overnight at 30℃with shaking at 200 rpm, and the genome of Streptomyces corset was extracted according to the instructions of TIANGEN bacterial genomic DNA extraction kit. PCR amplification was performed using the assxylR left F, assxylR left Rv primer, assxylR right F, assxylR right Rv primer, respectively, using the Phusion fidelity enzyme of NEB company, and the PCR amplified product was recovered by OMEGA gel recovery kit to obtain xylR left and xylR right homology arm fragments with a size of about 0.5kb.
PCR amplification was performed using the pSP72 plasmid as a template, using ass255-pSP72-F, ass255-pSP72-Rv primer, and using Phusion fidelity enzyme from NEB company. The OMEGA gel recovery kit recovered the PCR amplification product to give the backbond sequence of pSP72, approximately 2.5. 2.5 kb.
The synthesized glucose isomerase gene and rrnA DNA sequence were PCR amplified using ass403-GI-F, ass403-GI-Rv and assrrnA-F, assrrnA-Rv primers, respectively, with Phusion fidelity enzyme from NEB company, and the sizes of the products were 1.2kb and 0.5kb, respectively.
The PCR products obtained by the above extension were taken out and ligated using the GeneArt ™ Gibson Assembly and EX Cloning Kit. Ligation product conversionE. coliDH 5. Alpha. Competent cells were plated on LB plates containing 25. Mu.g/mL of apramycin, colony PCR was performed on the transformants, plasmids were extracted from positive transformants, and plasmids were sent to Suzhou gold and other intelligent biotechnology Co., ltd for sequencing, and the plasmid sequenced correctly was designated pXW403, and the map is shown in FIG. 1. The glucose isomerase integrated expression plasmid is constructed.
EXAMPLE 2 construction and fermentation verification of genetically engineered Strain recombinantly expressing glucose isomerase
Coli ET12567/pUZ8002 is used as donor bacteria for conjugal transfer, wherein plasmid pUZ8002 contains oriT conjugal transfer initiation site, which can assist transfer of target plasmid.
Firstly, the target plasmid pXW403 is transferred into the Escherichia coli ET12567/pUZ8002 by electrotransformation or chemical transformation method, and the Escherichia coli is cultivated to OD by LB containing the corresponding antibiotics 600 0.4-0.6, collecting thallus, washing twice with LB medium without antibiotic, and removing antibiotic from supernatant. Meanwhile, freshly harvested Streptomyces corset spores are suspended in a volume of 2 XYT medium (if spores stored in 20% glycerol, the glycerol is removed by centrifugation, washed twice with sterile water, and suspended in a volume of 2 XYT medium), heat-shocked at 50℃for 10min, and cooled sufficiently. Mixing the treated Streptomyces corset spores with Escherichia coli, coating on MS culture medium without antibiotics, culturing at 30deg.C for 12-16 hr, covering the plate with antibiotics corresponding to the target plasmid and naphthalenedone acid or trimethoprim An; the growth of the conjugative transfer was seen 2-3 days after the covering.
10 zygotes were streaked onto MS plates containing 25. Mu.g/mL of apramycin, and then each plate was inoculated with a single colony of seed medium 20 mL, and cultured at 28℃under shaking at 200 rpm for 48 h. Then respectively inoculating 2.5. 2.5 mL seed cultures into 50 mL fermentation medium, and shake culturing at 28deg.C and 200 rpm for 96 h;12000 Centrifuging at rpm for 10min to obtain supernatant; the glucose isomerase enzyme activities of the strain fermentation supernatants are respectively measured by a method for measuring the glucose isomerase activity of national standards of the people's republic of China (GB 23533-2009).
The results show that: the enzyme activity of glucose isomerase in the fermentation supernatant of one recombinant strain is up to 62.5U/mL, which is obviously higher than that of the other 9 recombinant strains. The applicant named the strain as Streptomyces corset JKX @ 101Streptomyces rubiginosusJKX 101). The fermentation supernatant of the strain was subjected to SDS-PAGE electrophoresis. The results are shown in FIG. 2, and the arrow points to the glucose isomerase expressed by the recombinant strain.
EXAMPLE 3 mutagenesis screening of glucose isomerase-producing high-yield strains
At present, two main methods for breeding industrial microorganisms exist: one is the traditional mutation breeding technology, and the other is the modern genetic engineering technology, namely, the production performance of the strain is improved by directionally modifying specific genes of the strain, but due to the protein expression of streptomyces, the expected aim is hardly achieved by changing single genes or regulatory factors. The traditional mutation breeding technology can obtain the strain with excellent production performance under the condition of not clarifying the genetic background of microorganisms only by repeatedly carrying out mutation breeding, fermentation and analysis. Therefore, the traditional mutation breeding technology is still an important means for streptomycete breeding.
Mutation caused by ultraviolet mutagenesis is very random, and the effect of mutation is also random and difficult to predict. Therefore, in order to obtain effective positive mutation, the skilled person is usually required to perform multiple rounds of ultraviolet mutagenesis, the screening effort is large, and there is a possibility that effective positive mutation cannot be obtained. However, since the equipment required for ultraviolet mutagenesis is simple and low in cost, and a large number of mutants can be obtained in a short time, it is still a commonly used mutagenesis breeding method.
The applicant uses the Streptomyces rust brown JKX101 constructed in example 2 as an initial strain, and genetically modifies the Streptomyces rust brown JKX by an ultraviolet mutagenesis method to further improve the yield of glucose isomerase.
3.1 preparation of monospore suspension
Taking a spore plate for culturing mature Streptomyces rust brown JKX101, adding sterile water, gently scraping spores with an inoculating loop, inoculating spore suspension containing spores into a 50 mL triangular flask with a plug, adding 5-10 glass beads, scattering spores on a 250 r/min shaking table, and filtering with filter paper to obtain monospore suspension with monospore content of more than 98%.
3.2 ultraviolet mutagenesis method
And (3) selecting a 30W ultraviolet lamp for irradiation, starting the ultraviolet lamp for preheating for 20 min before mutagenesis, and then placing an empty plate containing 200 mu L of bacterial suspension at a position which is about 20 cm away from the ultraviolet lamp for irradiation, wherein the irradiation time is respectively 10, 20, 30, 60, 90 and 120 s. After the irradiation is finished, 100 mu L of bacterial liquid is respectively taken from each culture dish, a flat plate is coated by dilution according to a certain concentration, and the culture is carried out in the dark at 28 ℃ for 3 to 5 dThe number of colonies of the single spore suspension coated plate without mutagenesis was used as a blank control, and the mortality M was calculated to determine the optimal UV irradiation time. The calculated formula of the mortality rate M is M= (N) 0 -N)/N 0 X 100%. Wherein: n (N) 0 For biomass density before mutagenesis, individual/mL; biomass density, in/mL, remained after N.
TABLE 1 ultraviolet mutagenesis mortality of Streptomyces carborundum JKX101
Time/s | 10 | 20 | 30 | 60 | 90 | 120 |
Mortality/% | 20.2 | 34.6 | 59.7 | 80.1 | 96.2 | 99.9 |
Too high or too low mortality is unfavorable for the occurrence of positive mutation, and the mortality rate is 70-80% and the effect is good. As can be seen from table 1: the mortality rate of the strain increases along with the increase of the irradiation time, and when the irradiation time is 60 s, the mortality rate of the strain reaches 80.1 percent; continuing to increase the irradiation time, the mortality rate of the strain had reached 96.2% at an irradiation time of 90 s. 60 s was therefore selected as the uv irradiation treatment time.
3.3 mutant Strain screening
And (3) taking spores which survive ultraviolet mutagenesis, properly diluting and coating on an MS plate, properly diluting spore suspension which is not subjected to mutagenesis treatment, coating the plate as a control, picking single colonies after spores on the plate grow to maturity, inoculating seed liquid into a fermentation medium for culturing for 48 hours, inoculating the seed liquid into the fermentation medium at an inoculum size of 5%, culturing for 4 d at a temperature of 28 ℃ at a speed of 200 r/min, and measuring the glucose isomerase activity of the supernatant of the fermentation liquid. Meanwhile, the original strain is used as a control, and 30 single colonies with glucose isomerase activity more than 30% of that of the original strain are selected for shake flask rescreening.
3.4 shaking bottle re-screening
And respectively inoculating the 30 mutant strains obtained by screening into a 50 mL shake flask fermentation medium, fermenting and culturing at 28 ℃ and 200 rpm for 96 h, centrifuging to obtain supernatant, respectively measuring the glucose isomerase enzyme activity in the fermentation supernatant, simultaneously taking the starting strain as a control, and selecting a mutant strain with the shake flask fermentation enzyme activity improved by more than 15% compared with the starting strain for carrying out second round of ultraviolet mutation screening.
The applicant continuously carries out 7 rounds of ultraviolet mutagenesis screening according to the method to finally obtain 1 mutant strain with the glucose isomerase yield obviously higher than that of the parent strain, and the mutant strain is named as Streptomyces corymbose JKX and JKX #Streptomyces rubiginosusJKX 102). After the strain is fermented and cultured in a 50 mL shake flask fermentation medium at 28 ℃ and 200 rpm for 96 h, supernatant is centrifugally taken, the activity of glucose isomerase in the supernatant is up to 96.4U/mL, which is 54.7% higher than that of the starting strain, and the activity of glucose isomerase in a 15L tank fermentation crude enzyme liquid is up to 925.3U/mL, which is 63.9% higher than that of the starting strain, so that unexpected technical effects are achieved.
Example 4 stability verification of Streptomyces rust brown JKX102
Streptomyces rust-brown JKX is inoculated in a seed culture medium, after 10 times of continuous subculture, 2.5 ml seed cultures are inoculated in a 50 mL fermentation culture medium for each passage, 96 h is cultivated at 28 ℃ under 200 rpm shaking, after fermentation is finished, supernatant is obtained by centrifugation at 12000 rpm for 10min, and glucose isomerase enzyme activities of the supernatant are respectively measured.
The results show that after 10 times of subculture, the fermentation enzyme activity of the Streptomyces corymbose JKX102 still exceeds 96.4U/mL, and the enzyme activity is not obviously reduced compared with that before the subculture. Therefore, the mutant strain of the high-yield glucose isomerase obtained by further screening by the ultraviolet mutagenesis method can still effectively keep the consistency of fermentation enzyme activities of different production batches, and has stable passage and remarkable effect.
The applicant has carried out the mutation of the strain Streptomyces carborundum JKX @ 5.2022Streptomyces rubiginosusJKX 102) is preserved in China center for type culture collection (CCTCC NO: M20221030) of university of Wuhan in Wuhan, china.
Claims (6)
1. The glucose isomerase is characterized in that the amino acid sequence of the glucose isomerase is SEQ ID NO. 1, and the encoding nucleotide sequence of the glucose isomerase is SEQ ID NO. 2.
2. A recombinant expression vector, characterized in that the recombinant expression vector carries a sequence encoded by SEQ ID NO:2, a glucose isomerase gene.
3. Streptomyces corymboseStreptomyces rubiginosus) The Streptomyces rust brown strain comprises the recombinant expression vector of claim 1 or 2.
4. The Streptomyces corset mutant strain is characterized in that the Streptomyces corset mutant strain is obtained by ultraviolet mutagenesis by taking the Streptomyces corset engineering strain as set forth in claim 3 as a starting strain.
5. The Streptomyces rust brown mutant strain according to claim 4, wherein the Streptomyces rust brown mutant strain has a preservation number of CCTCC NO: M20221030.
6. Use of the mutant Streptomyces rust brown bacteria according to claim 4 or 5 for the production of high fructose syrups.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210816219.3A CN116445465A (en) | 2022-07-10 | 2022-07-10 | Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210816219.3A CN116445465A (en) | 2022-07-10 | 2022-07-10 | Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116445465A true CN116445465A (en) | 2023-07-18 |
Family
ID=87122540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210816219.3A Pending CN116445465A (en) | 2022-07-10 | 2022-07-10 | Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116445465A (en) |
-
2022
- 2022-07-10 CN CN202210816219.3A patent/CN116445465A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104894047B (en) | The construction method of the recombined bacillus subtilis of the epimerase of expression D psicoses 3 based on D alanine deficiency selection markers | |
CN105602879B (en) | Engineering strain, construction method and its application of one plant of efficient secretion D-Psicose 3- epimerase | |
CN108165515B (en) | Multi-copper oxidase recombinase capable of degrading biogenic amine | |
CN113801832B (en) | Bacillus subtilis for high yield of psicose epimerase and application thereof | |
CN103131721B (en) | Nucleotide sequence of D-tagatose-3-epimerase (DTE) of ruminococcus sp. and use thereof | |
EP4276171A1 (en) | Bacillus subtilis genetically engineered bacterium for producing tagatose and method for preparing tagatose | |
CN112029752B (en) | Ulva lactuca polysaccharide lyase as well as coding gene and application thereof | |
JP6975239B2 (en) | Psicose Epimerization Enzyme-producing Psicose production method using microorganisms | |
US10612007B2 (en) | Method for increasing citric acid production by Aspergillus niger fermentation | |
CN114540231A (en) | Pediococcus acidilactici for promoting generation of flavor substances in fermented food and application thereof | |
CN110423701B (en) | Aspergillus niger strain for high yield of arabinofuranosidase | |
DE60035801T2 (en) | BACTERIAL STRAINS OF GENUS KLEBSIELLA AND ITS GENERATING ENCODES FOR ISOMALTULOSE SYNTHASE | |
CN113249287B (en) | Bacillus subtilis engineering strain for expressing D-psicose 3-epimerase and application thereof | |
KR20160081722A (en) | Method for producing psicose using the same | |
CN113106112B (en) | Genetically engineered bacterium for heterologously expressing xanthan endonuclease and application thereof | |
CN106995794A (en) | A kind of Actinobacillus succinogenes engineered strain and its construction method and purposes for improving succinic acid yield | |
CN104962508A (en) | Toxalbumin MazF reverse screening-based method for building recombinant Bacillus subtilis for expression of D-psicose 3-epimerase Bacillus subtilis | |
CN103695323B (en) | Stable and high-yield strain for alpha-transglucosidase | |
KR20100040438A (en) | A novel agarase and an enzymatic production method of agarooligosaccharide from agarose using the same | |
CN116445465A (en) | Method for efficiently expressing glucose isomerase in Streptomyces corset and recombinant mutant | |
CN103695383B (en) | Aspergillus niger strain for efficiently expressing alpha-transglucosidase | |
CN115960731A (en) | Construction method and application of recombinant strain for increasing gibberellin GA3 content by degrading down-regulated squalene content with protein | |
CN116218830A (en) | Bacillus subtilis strain for high yield of glucose isomerase and application thereof | |
CN110106153A (en) | A kind of blue multicopper oxidase mutant that salt tolerance improves | |
KR101091150B1 (en) | Novel Bacillus sp.HY―20 strain isolated from Apis melifera and xylanase produced from it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |